Seeking Alpha

Cerus (CERS) announces a secondary offering for an undisclosed amount. The company anticipates...

Cerus (CERS) announces a secondary offering for an undisclosed amount. The company anticipates using the net proceeds for clinical development and other R&D and marketing activities related to its Intercept Blood System, plus other general corporate purposes. CERS may also use a portion of the net proceeds from the offering to prepay the remaining outstanding indebtedness under its growth capital loan with Comerica Bank. Cowen is acting as sole book-runner. Shares -0.5% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|